Statistics for Interleukin‐receptor antagonist and tumor necrosis factor inhibitors for theprimary and secondary prevention of atherosclerotic cardiovascular diseases.
Total visits
| views | |
|---|---|
| Interleukin‐receptor antagonist and tumor necrosis factor inhibitors for theprimary and secondary prevention of atherosclerotic cardiovascular diseases. | 211 |
Total visits per month
| views | |
|---|---|
| marzo 2024 | 1 |
| abril 2024 | 14 |
| mayo 2024 | 6 |
| junio 2024 | 0 |
| julio 2024 | 0 |
| agosto 2024 | 0 |
| septiembre 2024 | 0 |
File Visits
| views | |
|---|---|
| Interleukin‐receptor antagonist and tumor necrosis factor inhibitors for the primary and secondary prevention of atherosclerotic cardiovascular diseases - Martí-Carvajal, AJ - 2021 _ Cochrane Library.pdf | 65 |